Delivery Order 47QTCA18D0071-75F40123F80143
- This is a labor-hour award made by the U.S. Food and Drug Administration (FDA) to Agisol LLC, an 8(a) certified small disadvantaged business, to provide regulatory review of the Document Archiving, Reporting, and Regulatory Tracking System (DARRTS) production support services for the Center for Drug Evaluation and Research (CDER). The contract, valued at $4,499,636.43, runs from the award date of February 4, 2024 through December 17, 2025. Agisol LLC has extensive experience supporting the FDA's...
- The U.S. Food and Drug Administration (FDA) awarded a $1,189,125.49 time-and-materials contract to Agisol LLC, an SBA-certified 8(a) and Economically Disadvantaged Women-Owned Small Business (EDWOSB), to streamline processes and enhance new drug review services. This contract was issued under the 8(a) STARS III Government-Wide Acquisition Contract (GWAC), a $50 billion multiple-award contract vehicle for IT services and solutions. Agisol LLC specializes in providing IT services and solutions...
- The Department of Health and Human Services Food and Drug Administration (HHS FDA) awarded a one-year, $1.5 million firm fixed price delivery order contract to Agisol LLC. The contract is for CDER Regulatory Review Systems and Data Support under the Multiple Award Schedule contract vehicle. As the prime, Agisol will provide information technology services and solutions to support HHS FDA's Center for Drug Evaluation and Research programs. No subcontractors or set aside designations were...
- The Department of Health and Human Services Food and Drug Administration awarded a $3.8 million definitive contract to Agisol LLC of Silver Spring, Maryland. The contract is for the DOCUMENT ARCHIVING, REPORTING, AND REGULATORY TRACKING SYSTEM and has a period of performance from January 21, 2022 to January 17, 2024. The pricing structure is firm fixed price. The contract was set aside for 8(a) Sole Source small businesses. Agisol LLC will provide document archiving, reporting, and regulatory...
- Agisol LLC, an 8(a) certified Economically Disadvantaged Small Woman Owned business, has been awarded a $855,193.20 definitive contract by the Department of Health and Human Services' Food and Drug Administration (HHS FDA) to streamline processes and enhance new drug review under an 8(a) sole source set aside designation. The contract has a completion date of September 25, 2022 and pricing is set as time and materials. Agisol LLC will draw from its experience providing IT services and...
- This is a federal contract award from the U.S. Food and Drug Administration (FDA) to Agisol LLC, an SBA-certified 8(a) Program participant and Economically Disadvantaged Women-Owned Small Business (EDWOSB). The contract is for $2,538,816.41 and provides office support services to the FDA's Office of Clinical Policy. The contract is a Delivery Order issued under the 8(a) STARS III Government-Wide Acquisition Contract (GWAC), a $50 billion multiple-award contract vehicle for IT services and...
- This is a sole source 8(a) contract awarded by the Department of Health and Human Services Food and Drug Administration (HHS FDA) to Agisol LLC, a Minority Owned, Economically Disadvantaged, Women-Owned Small Business (EDWOSB) located in the DC Metro area. The contract, valued at $899,910.69, is for business process user support services to the Center for Drug Evaluation and Research (CDER) at the FDA. Agisol LLC has received over $15 million in prime federal contracts from HHS FDA, including...
- This is a Firm Fixed Price delivery order contract awarded by the Food and Drug Administration (FDA) to Agisol LLC, a small business registered to receive federal contract awards since 2014. The objective of this order is to acquire expert consulting support and services to support the mission of the FDA's Office of Business Informatics (OBI). Agisol LLC, an SBA-certified 8(a) Program participant and Economically Disadvantaged Women-Owned Small Business (EDWOSB), will provide operational and...
- This is a Task Order awarded by the Department of Health and Human Services' Food and Drug Administration (HHS FDA) to Deloitte & Touche LLP, a large professional services firm, under the FDA Safety And Innovation Act Support Services (FDASIA) Blanket Purchase Agreement (BPA). The Task Order, valued at $7,218,610.25, is for analysis and reporting analytics of the FDA's drug safety platform. There is no set-aside designation for this award. Deloitte has subcontracted a portion of the work...
- This is a $5,968,470.83 task order awarded under the FDA Safety And Innovation Act Support Services (FDASIA) blanket purchase agreement (BPA) to Deloitte & Touche LLP, a major federal contractor. The task order is for implementing the Drug Safety Modernization Act, with a performance period through December 2022. It is not set-aside. Deloitte has subcontracted portions of the work to Skillstorm Commercial Services LLC and Agisol LLC, a small disadvantaged 8(a) firm. The Food and Drug...
- Multiple Award Schedule (MAS)Master GSA Schedule
- 47QTCA18D0071Federal Supply Schedule
- 47QTCA18D0071-75F40123F80143Delivery Order
The U.S. Food and Drug Administration (FDA) has awarded a $4,481,143.91 Delivery Order contract to Agisol LLC, an 8(a) certified small disadvantaged business, for CDER Streamline Process and Enhance Functions for New Drug Review. This is a Time and Materials contract awarded under the GSA Multiple Award Schedule (MAS) vehicle. Agisol LLC is a small IT services provider that specializes in supporting the FDA's regulatory review and research activities, including work on systems like the Document Archiving, Reporting, and Regulatory Tracking System (DARRTS) and the Enterprise Data Architecture for Regulatory Review (EDARR) initiative. The contract has an ultimate completion date of July 31, 2028 and was awarded on June 8, 2023 as an 8(a) sole source set-aside.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| P00003 | Exercise an Option | $638.9k | 6/23/25 | |
| P00002 | Other Administrative Action | $0 | 5/22/25 | |
| P00001 | Other Administrative Action | $699.5k | 7/23/24 | |
| Not listed | Not listed | $999.7k | 6/8/23 |